BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17504390)

  • 1. Cerebro-fronto-facial syndrome (Dandy-Walker Variant and frontofacial dysmorphisms): report of the first case identified by increased nuchal translucency beyond 13(+6) weeks.
    Tonni G; Azzoni D; Ambrosetti F; de Felice C; Ventura A
    Congenit Anom (Kyoto); 2007 Jun; 47(2):68-71. PubMed ID: 17504390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
    Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
    Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population.
    Prefumo F; Sethna F; Sairam S; Bhide A; Thilaganathan B
    Obstet Gynecol; 2005 Jun; 105(6):1348-54. PubMed ID: 15932828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS).
    Yalinkaya A; Yayla M; Erdemoglu M
    Prenat Diagn; 2007 Sep; 27(9):856-7. PubMed ID: 17605153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness model for first-trimester versus second-trimester ultrasound screening for Down syndrome.
    Kott B; Dubinsky TJ
    J Am Coll Radiol; 2004 Jun; 1(6):415-21. PubMed ID: 17411619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fetal dandy walker complex: associated anomalies, perinatal outcome and postnatal imaging.
    Harper T; Fordham LA; Wolfe HM
    Fetal Diagn Ther; 2007; 22(4):277-81. PubMed ID: 17369695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal cystic malformations of the posterior fossa in the first trimester of pregnancy.
    Nizard J; Bernard JP; Ville Y
    Fetal Diagn Ther; 2005; 20(2):146-51. PubMed ID: 15692211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester ultrasonography in screening and detection of fetal anomalies.
    Sonek J
    Am J Med Genet C Semin Med Genet; 2007 Feb; 145C(1):45-61. PubMed ID: 17304542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of 13q-syndrome in a fetus with Dandy-Walker malformation.
    Gul A; Cebeci A; Erol O; Ceylan Y; Basaran S; Yuksel A
    Obstet Gynecol; 2005 May; 105(5 Pt 2):1227-9. PubMed ID: 15863591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of a partial 6q trisomy: a case report.
    Valerio D; Di Domenico A; Felicetti M; La Boccetta A; Ferrara C; Antonio N; Borrelli AL
    Prenat Diagn; 2006 Oct; 26(10):917-9. PubMed ID: 16845680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal diagnosis and obstetric management of Dandy-Walker syndrome.
    Pilu G; Romero R; De Palma L; Rizzo N; Jeanty P; Copel JA; Bovicelli L; Hobbins JC
    J Reprod Med; 1986 Nov; 31(11):1017-22. PubMed ID: 3543341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nuchal translucency thickness: a potential indicator for Ritscher-Schinzel syndrome.
    Rusnak AJ; Hadfield MI; Chudley AE; Marles SL; Reid GJ; Chodirker BN
    Fetal Diagn Ther; 2008; 24(4):395-9. PubMed ID: 18957854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses.
    Schou KV; Kirchhoff M; Nygaard U; Jørgensen C; Sundberg K
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):618-22. PubMed ID: 19953565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural heart defects associated with an increased nuchal translucency: 9 years experience in a referral centre.
    Clur SA; Mathijssen IB; Pajkrt E; Cook A; Laurini RN; Ottenkamp J; Bilardo CM
    Prenat Diagn; 2008 Apr; 28(4):347-54. PubMed ID: 18382996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long term follow-up of children with increased nuchal translucency and normal karyotype on first trimester sonography].
    Jenewein N; Scheier M; Kiechl-Kohlendorfer U
    Klin Padiatr; 2009; 221(1):14-8. PubMed ID: 18989839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
    Palomaki GE; Neveux LM; Haddow JE; Wyatt P
    Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.